骨内注射万古霉素用于初次全膝关节置换术后急性肾损伤发生率低于静脉注射
单中心回顾性研究纳入4184例初次全膝关节置换术,比较骨内注射万古霉素(IOV,1297例)与静脉注射万古霉素(IVV,2887例)术后急性肾损伤(AKI)发生率。IOV组AKI发生率显著低于IVV组(1.9% vs 3.3%,P=0.017),IVV与AKI风险独立相关(OR 1.87,95%CI 1.09-3.21)。IOV技术未观察到不良事件。
要点
- IOV组术后AKI发生率1.9%,显著低于IVV组的3.3%(P=0.017)。
- IVV是AKI的独立危险因素(OR 1.87,95%CI 1.09-3.21)。
- 发生AKI患者住院时间更长且更易转至专业护理机构。
核心结论
- 与IVV相比,IOV用于初次TKA预防可显著降低术后AKI发生率。
主要发现
- IOV组AKI发生率为1.9%,IVV组为3.3%(P=0.017)。
- 发生AKI的患者住院时间更长(59.9±39.1小时 vs 42.1±33.3小时,P<0.001),出院转至专业护理机构比例更高(10.1% vs 3.0%,P<0.001)。
- 逻辑回归显示IVV(OR 1.87,95%CI 1.09-3.21)、体重指数(OR 1.09,95%CI 1.05-1.13)和术后血尿素氮(OR 1.29,95%CI 1.24-1.35)与AKI显著相关。
- IOV技术未观察到不良事件。
关键数值与推荐
- AKI定义为肌酐较基线升高0.3 mg/dL。
临床怎么用
- 初次TKA围手术期预防可考虑采用IOV替代IVV以降低AKI风险,尤其对高风险患者。
局限性
- 本研究为单中心回顾性设计,可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative vancomycin administration can be difficult to time and can lead to adverse systemic effects. Intraosseous vancomycin (IOV) is becoming increasingly utilized for total knee arthroplasty (TKA) prophylaxis. The primary purpose was to compare the rate of acute kidney injury (AKI) following primary TKA that utilized IOV or intravenous vancomycin (IVV). METHODS: A single-institution retrospective review was conducted on 4,184 primary TKAs from July 2016 to November 2024 that received IOV (1,297 cases) or IVV (2,887 cases) as part of antibiotic prophylaxis. All included patients had a basic metabolic panel on postoperative day 1. Patients were excluded if they had a solid organ transplant, were on dialysis, or received a blood transfusion following TKA. An AKI was defined as a creatinine increase of 0.3 mg/dL from baseline. Data were analyzed using independent samples t-tests and Chi-square analyses. Logistic regressions were used to identify significant risk factors for AKI. RESULTS: The rate of AKI was lower in the IOV than the IVV group (1.9 versus 3.3%, P = 0.017). Patients who developed AKI had longer hospitalizations (59.9 ± 39.1 hours versus 42.1 ± 33.3, P < 0.001) and a higher likelihood of discharge to skilled nursing facilities (10.1 versus 3.0%, P < 0.001) than non-AKI patients. Logistic regression demonstrated that IVV (odds ratio [OR]: 1.87; 95% confidence interval [CI] 1.09 to 3.21), body mass index (OR 1.09; 95% CI 1.05 to 1.13), and postoperative blood urea nitrogen (OR 1.29; 95% CI 1.24 to 1.35) were significantly associated with AKI. There were no adverse events observed due to the IOV technique. CONCLUSIONS: The use of IOV was associated with a significantly lower rate of AKI following primary TKA when compared to IVV. Administering vancomycin with an IO technique avoids the difficulties of incomplete administration prior to incision and reduces systemic side effects.
引用
- Aflatooni JO, Wininger AE, Sullivan TC, et al. Intraosseous Vancomycin for Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Postoperative Acute Kidney Injury Than Intravenous Vancomycin. J Arthroplasty. 2026. PMID: 41850507. doi:10.1016/j.arth.2026.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。